Andrew Vickers, PhD, who works at the Memorial Sloan-Kettering Cancer Center in New York, is not a physician. He is a statistician and a research methodologist. And he is a member of the Scientific Advisory Board to The “New” Prostate Cancer InfoLink. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: outcome, patient-reported, pro, research, validation, Vickers | 2 Comments »
It appears that when it comes to the new data to be presented at ASCO this year, this will be the first time for several years that we don’t see some really groundbreaking new data from a large Phase III trial of some new form of therapy at one of the major meetings. But there is a lot of detail and a lot of information about new trials in development. … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: endpoint, hypothesis, surrogate, validation | Leave a comment »
Another new article (to be published in European Urology) has used data from > 25,000 patients to validate the proposed IUSP grading system, scheduled to replace the Gleason grading system over the next few years. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: grading, ISUP, new, system, validation | 10 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 